Hemp & Health (WAR:HMP) Marketable Securities: zł1.17 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:HMP Hemp & Health SA WAR:HMP
30 GF Score
Price zł0.35
GF Value zł0.32
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Hemp & Health Marketable Securities?

Hemp & Health WAR:HMP 30 Marketable Securities is zł1.17 Mil as of Mar. 2026. GuruFocus rates WAR:HMP with a GF Score™ of 30/100 and a GF Value™ of zł0.32 (Fairly Valued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Hemp & Health's Marketable Securities for the quarter that ended in Mar. 2026 was zł1.17 Mil.

Hemp & Health's annual Marketable Securities declined from Dec. 2023 (zł2.54 Mil) to Dec. 2024 (zł2.25 Mil) and declined from Dec. 2024 (zł2.25 Mil) to Dec. 2025 (zł1.37 Mil).

Hemp & Health  (WAR:HMP) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Hemp & Health Marketable Securities Related Terms

Hemp & Health Marketable Securities Historical Data

* Premium members only.

The historical data trend for Hemp & Health's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemp & Health Marketable Securities Chart

Hemp & Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.56 0.00 2.54 2.25 1.37

Hemp & Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.90 1.94 1.55 1.37 1.17
WAR:HMP
30GF Score
Hemp & Health SA WAR:HMP
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemp & Health Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of zł1.17 Mil mean?
Hemp & Health (WAR:HMP) has a Marketable Securities of zł1.17 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hemp & Health and its competitors.
Is Hemp & Health's Marketable Securities too high?
Hemp & Health's current Marketable Securities is zł1.17 Mil. Overall, Hemp & Health has a GF Score™ of 30/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hemp & Health's Marketable Securities compare to ZTS and UTHR?
Hemp & Health's Marketable Securities of zł1.17 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hemp & Health and its competitors. Hemp & Health's current Marketable Securities is zł1.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemp & Health stock overvalued right now?
Based on GuruFocus' analysis, Hemp & Health (WAR:HMP) is currently considered Fairly Valued. The stock's GF Value™ is zł0.32, compared to a current price of zł0.35 — trading 9.7% above its estimated fair value. The current Marketable Securities is zł1.17 Mil. Hemp & Health's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Hemp & Health (WAR:HMP), the current Marketable Securities is zł1.17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hemp & Health (WAR:HMP) Overvalued in 2026?

Based on GuruFocus' analysis, Hemp & Health stock appears to be overvalued. The current stock price of zł0.35 is trading 9.7% above its estimated GF Value™ of zł0.32. GuruFocus considers Hemp & Health to be Fairly Valued.

Key valuation signals for WAR:HMP:

  • Marketable Securities: zł1.17 Mil
  • GF Value™: zł0.32 vs. price of zł0.35 (9.7% above fair value)
  • GF Score™: 30/100 with 4 warning signs

No single metric tells the full story. See the WAR:HMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hemp & Health Business Description

Address ul. Jana Styki 23, Warsaw, POL, 03-928
Hemp & Health SA is engaged in hemp and cannabis cultivation. The company processes harvested crops such as CBD and CBG, used for the production of white labels and private labels oils, creams, dried herbs and liquids for vaporization.
30GF Score

Get the complete analysis for WAR:HMP

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.35
Price
zł0.32
GF Value